Home › Funds › Advocacy Wealth Management, LLC › ABT

Advocacy Wealth Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Advocacy Wealth Management, LLC reported holding 143,444 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$14.2M, representing 0.51% of its reported portfolio and ranking #39 among its reported holdings. Advocacy Wealth Management, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)143.44K sh
Reported value held$14.18M
Portfolio Weight0.51%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Advocacy Wealth Management, LLC's ABT position evolved

Advocacy Wealth Management, LLC first disclosed a stake in ABT in Q3 2025 at 127,846 shares (US$17.1M). Across 5 filings, Advocacy Wealth Management, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 143,444 shares valued at US$14.2M — an increase of 27,497 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 127.85K $17.12M New
Q4 2025 126.92K $15.90M Reduce
Q1 2026 124.01K $12.73M Reduce
Q2 2026 115.95K $10.52M Reduce
Q3 2026 143.44K $14.18M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Advocacy Wealth Management, LLC held ABT?

Advocacy Wealth Management, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Advocacy Wealth Management, LLC's current position in ABT?

As of Q3 2026, Advocacy Wealth Management, LLC holds 143.44K shares of ABT (ABBOTT LABORATORIES), valued at $14.18M, representing 0.51% of its reported portfolio and ranking #39.

Has Advocacy Wealth Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Advocacy Wealth Management, LLC increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.